Home › Stocks › ASND › Changes
Who bought & sold ASND (Q2 2026)
Funds holding (Q2 2026)326
New positions84
Added100
Reduced105
Exited69
As of Q2 2026, 326 institutional funds reported holding ASND (ASCENDIS PHARMA A/S): 84 opened new positions, 100 added, 105 trimmed and 69 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.
New positions (20 of 84)
Added to positions (20 of 100)
| Fund | Shares | Value | Weight | Change |
|---|---|---|---|---|
| Wellington Management Group | 1.55M | $413.05M | 0.1 | +1.08M sh (+228.8%) |
| WELLINGTON MANAGEMENT GROUP LLP | 1.55M | $413.05M | 0.1 | +1.08M sh (+228.8%) |
| T. Rowe Price Investment Management, Inc. | 6.75M | $1.80B | 1.2 | +592.80K sh (+9.6%) |
| Geode Capital Management | 403.15K | $107.53M | 0.0 | +330.21K sh (+452.7%) |
| PFM Health Sciences, LP | 233.17K | $62.19M | 5.4 | +210.77K sh (+940.9%) |
| UBS Group AG | 401.88K | $107.19M | 0.0 | +194.54K sh (+93.8%) |
| Millennium Management | 328.71K | $87.67M | 0.0 | +139.68K sh (+73.9%) |
| Empowered Funds, LLC | 187.27K | $49.95M | 0.3 | +136.14K sh (+266.2%) |
| ODDO BHF ASSET MANAGEMENT SAS | 128.66K | $34.32M | 1.7 | +128.50K sh (+79811.2%) |
| ALLIANCEBERNSTEIN L.P. | 399.29K | $106.50M | 0.0 | +121.09K sh (+43.5%) |
| Frazier Life Sciences Management, L.P. | 225.16K | $60.05M | 1.3 | +91.82K sh (+68.9%) |
| BNY Mellon | 319.41K | $85.19M | 0.0 | +90.74K sh (+39.7%) |
| Nuveen, LLC | 90.32K | $24.09M | 0.0 | +84.27K sh (+1392.6%) |
| Citadel Advisors | 93.10K | $24.83M | 0.0 | +83.10K sh (+831.0%) |
| SILVERARC CAPITAL MANAGEMENT, LLC | 206.23K | $55.01M | 6.4 | +81.58K sh (+65.4%) |
| ORBIMED ADVISORS LLC | 244.46K | $65.20M | 1.3 | +62.48K sh (+34.3%) |
| Northern Trust Corp | 103.93K | $27.72M | 0.0 | +58.96K sh (+131.1%) |
| CPP Investments | 85.48K | $22.80M | 0.0 | +54.81K sh (+178.8%) |
| Avoro Capital Advisors LLC | 5.11M | $1.36B | 12.2 | +48.61K sh (+1.0%) |
| RHUMBLINE ADVISERS | 48.61K | $12.97M | 0.0 | +46.89K sh (+2718.1%) |
Reduced positions (20 of 105)
| Fund | Shares | Value | Weight | Change |
|---|---|---|---|---|
| Franklin Resources | 1.86M | $496.77M | 0.1 | -45.46M sh (-96.1%) |
| AMERIPRISE FINANCIAL INC | 320.51K | $85.49M | 0.0 | -7.09M sh (-95.7%) |
| BlackRock Inc | 2.21M | $589.94M | 0.0 | -6.96M sh (-75.9%) |
| BNP PARIBAS FINANCIAL MARKETS | 173.45K | $46.26M | 0.1 | -3.47M sh (-95.2%) |
| Balyasny Asset Management | 31.02K | $8.27M | 0.0 | -2.97M sh (-99.0%) |
| Polar Capital Holdings Plc | 616.91K | $164.54M | 0.5 | -2.88M sh (-82.4%) |
| Bank of America Corp | 260.64K | $69.52M | 0.0 | -2.82M sh (-91.5%) |
| Invesco Ltd | 414.20K | $110.47M | 0.0 | -2.44M sh (-85.5%) |
| Morgan Stanley | 544.39K | $145.20M | 0.0 | -2.35M sh (-81.2%) |
| Wells Fargo & Co | 50.35K | $13.43M | 0.0 | -1.78M sh (-97.3%) |
| BARCLAYS PLC | 76.54K | $20.41M | 0.0 | -1.75M sh (-95.8%) |
| JANE STREET GROUP, LLC | 26.30K | $7.01M | 0.0 | -1.17M sh (-97.8%) |
| Artisan Partners Limited Partnership | 2.63M | $702.55M | 1.2 | -596.16K sh (-18.5%) |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.12M | $299.40M | 0.0 | -407.82K sh (-26.6%) |
| T. Rowe Price Associates | 1.12M | $299.40K | 0.0 | -407.82K sh (-26.6%) |
| ROYAL BANK OF CANADA | 27.28K | $7.28M | 0.0 | -397.72K sh (-93.6%) |
| PERCEPTIVE ADVISORS LLC | 1.16M | $310.39M | 4.9 | -367.70K sh (-24.0%) |
| Fidelity Management & Research (FMR) | 3.55M | $945.68M | 0.0 | -331.03K sh (-8.5%) |
| JPMorgan Chase & Co | 367.78K | $96.98M | 0.0 | -328.22K sh (-47.2%) |
| Caption Management, LLC | 25.50K | $6.80M | 0.1 | -221.50K sh (-89.7%) |
Exited positions (20 of 69)
Held in the prior quarter but not reported in the latest filing.